High-Intensity Exercise Acutely Increases Substantia Nigra and Prefrontal Brain Activity in Parkinson’s Disease

Related articles

25 Mar 2020 : Laboratory Research

An Integrated Network Analysis of mRNA and Gene Expression Profiles in Parkinson’s Disease

Yaping Wang, Zhiyun Wang

DOI: 10.12659/MSM.920846

07 Feb 2019 : Clinical Research

Comparison of Quantitative Electroencephalogram During Sleep in Depressed and Non-Depressed Patients with Parkinson’s Disease

Ke Liu, QinYing Ma, [...] MingWei Wang - Show fewer authors

DOI: 10.12659/MSM.913931

03 Aug 2019 : Laboratory Research

The Neuroprotective Effect of Steroid Receptor Coactivator-Interacting Protein (SIP) in Astrocyte Model of 1-Methyl-4-Phenylpyridinium (MPP⁺)-Induced Parkinson’s Disease

Mingwei Qu,

DOI: 10.12659/MSM.912106

22 Oct 2018 : Animal Research

Interleukin-1 Beta and Tumor Necrosis Factor Alpha Upregulation and Nuclear Factor Kappa B Activation in Skeletal Muscle from a Mouse Model of Chronic/Progressive Parkinson Disease

Nour Erekat, Muhammed D. Al-Jarrah

DOI: 10.12659/MSM.909032

02 Apr 2017 : Laboratory Research

MicroRNA-181a Regulates Apoptosis and Autophagy Process in Parkinson’s Disease by Inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)/c-Jun N-Terminal Kinases (JNK) Signaling Pathways

Ying Liu, Yanfeng Song, [...] Xiaotun Zhu - Show fewer authors

DOI: 10.12659/MSM.900218

02 Jun 2017 : Laboratory Research

Resolvin D1 Attenuates Mpp+-Induced Parkinson Disease via Inhibiting Inflammation in PC12 Cells

Jinyan Xu, Xiang Gao, [...] Chunying Yang, Li Chen, Zhengjun Chen - Show fewer authors

DOI: 10.12659/MSM.901995

25 Sep 2017 : Clinical Research

Differences in ABCA1 R219K Polymorphisms and Serum Indexes in Alzheimer and Parkinson Diseases in Northern China

Lagai Ya, Zuneng Lu

DOI: 10.12659/MSM.903636

18 Jun 2017 : Laboratory Research

Increased Levels of Pro-Inflammatory and Anti-Inflammatory Cellular Responses in Parkinson’s Disease Patients: Search for a Disease Indicator

Likun Yang, Changfeng Guo, [...] Jie Zhu, Yi Feng, Weiliang Chen, Zhizhong Feng, Dan Wang, Shibai Sun, Wei Lin, Yuhai Wang - Show fewer authors

DOI: 10.12659/MSM.904240

10 Nov 2017 : Clinical Research

High Performance Liquid Chromatography-Mass Spectrometry (LC-MS) Based Quantitative Lipidomics Study of Ganglioside-NANA-3 Plasma to Establish Its Association with Parkinson’s Disease Patients

Jinzhi Zhang, Xiao Zhang, [...] Lijuan Wang, Caidi Yang - Show fewer authors

DOI: 10.12659/MSM.904399

13 May 2016 : Laboratory Research

Association of Dopamine Beta-Hydroxylase (DBH) Polymorphisms with Susceptibility to Parkinson’s Disease

Peng Shao, Yun-xia Yu, [...] Jing-xi Bao - Show fewer authors

DOI: 10.12659/MSM.895798

03 Aug 2016 : Original article

Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson’s Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study

Frederick J.A. Meijer, Stefan C. Steens, [...] Anouke van Rumund, Anne-Marie van Cappellen van Walsum, Benno Küsters, Rianne A.J. Esselink, Marcel M. Verbeek, Bastiaan R. Bloem, Bożena Goraj - Show fewer authors

DOI: 10.12659/PJR.897090

23 May 2016 : Laboratory Research

CD200 Inhibits Inflammatory Response by Promoting KATP Channel Opening in Microglia Cells in Parkinson’s Disease

Yi Ren, Min Ye, [...] Shengdi Chen, Jianqing Ding - Show fewer authors

DOI: 10.12659/MSM.898400

02 Dec 2016 : Case report

Three Cases of Levodopa-Resistant Parkinsonism After Radiation Therapy

Raja Mehanna, Joohi Jimenez-Shahed, [...] Ilia Itin - Show fewer authors

DOI: 10.12659/AJCR.900537

11 Aug 2014 : Short communication

Dopamine Transporter Imaging Using 99mTc-TRODAT-1 SPECT in Parkinson’s Disease

Edson Bor-Seng-Shu, Andre C. Felicio, [...] Pedro Braga-Neto, Ilza Rosa Batista, Wellingson Silva Paiva, Daniel Ciampi de Andrade, Manoel Jacobsen Teixeira, Luis Augusto Franco de Andrade, Orlando Graziani Povoas Barsottini, Ming Chi Shih, Rodrigo A. Bressan, Henrique Ballalai Ferraz - Show fewer authors

DOI: 10.12659/MSM.890522

07 May 2014 : Original article

The effects of morphine on Parkinson’s-related genes PINK1 and PARK2

Christopher Snyder, Kirk Mantione

DOI: 10.12659/MSMBR.890557

11 Nov 2014 : Original article

Ophthalmological Features of Parkinson Disease

Barbara Nowacka, Wojciech Lubinski, [...] Krystyna Honczarenko, Andrzej Potemkowski, Krzysztof Safranow - Show fewer authors

DOI: 10.12659/MSM.890861

06 Nov 2014 : Research paper

Analysis of Thr12Met and Ala1144Thr Mutations of the ATP13A2 Gene in Parkinson’s Disease Patients in Xinjiang Uygur and Han Ethnic Groups

Guihua Li, Zhenzhong Zhang, [...] Huan Xia, Xinling Yang - Show fewer authors

DOI: 10.12659/MSM.892821

01 Aug 2012

Parkinson’s disease, L-DOPA, and endogenous morphine: A revisit

George B. Stefano, Kirk J. Mantione, [...] Milena Králíčková, Radek Ptacek, Hana Kuzelova, Tobias Esch, Richard M. Kream - Show fewer authors

DOI: 10.12659/MSM.883259

01 Feb 2010

Melatonin MT1 and MT2 receptor expression in Parkinson's disease

Nikhil Adi, Deborah C Mash, [...] Yousuf Ali, Carlos Singer, Lina Shehadeh, Spyridon Papapetropoulos - Show fewer authors

21 Feb 2009

Blink reflex changes in parkinsonism following severe traumatic brain injury correlates with diffuse axonal injury

Rita Formisano, Paola Cicinelli, [...] Maria Gabriella Buzzi, Stefano Brunelli, Ross Zafonte, Vincenzo Vinicola, Andrea Gabrielli, Umberto Sabatini - Show fewer authors

01 Apr 2008

Differences in WHOQOL-100 domain scores in Parkinson’s disease and osteoarthritis

Vaineta Valeikiene, Jelena Ceremnych, [...] Vidmantas Alekna, Algirdas Juozulynas - Show fewer authors

01 Jan 2005

Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.

Yu Watanabe, Toshiki Himeda, [...] Tsutomu Araki - Show fewer authors

01 Mar 2005 : Original article

Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease

Alexander M. Goberman,

02 Jul 2004

Botulinum toxin type B for gait freezing in Parkinson’s disease

Hubert H. Fernandez, Margaret C. Lannon, [...] Martha E. Trieschmann, Joseph H. Friedman - Show fewer authors

01 Dec 2004

Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson’s disease

Elisenda Sanz, Manuel Romera, [...] Lydia Belyk, J I Marco, Mercedes Unzeta - Show fewer authors

07 Aug 2002

Immune processes in the pathogenesis of Parkinson’s disease – a potential role for microglia and nitric oxide

Anna Członkowska, Iwona Kurkowska-Jastrzębska, [...] Andrzej Członkowski, Doris Peter, George B. Stefano - Show fewer authors